Supernus announces FDA approval of ONAPGO
Pharmaceuticals announced that the U.S. Food and Drug Administration, FDA, approved ONAPGO injection, formerly known as ...
U.S. FDA approves Supernus' drug-device combination for Parkinson's disease
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat movement-related symptoms of Parkinson's disease, the drugmaker said on Tuesday.
Clarivate Plc: Clarivate Reveals Medtech Breakthroughs Driving Growth in Pulsed Field Ablation Market
New e-book explores transformative medtech advancements in pulsed field ablation for atrial fibrillation treatment LONDON, Feb. 4, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) a leading ...
Gilead: Strong Sales Growth Remains With Veklury And Beyond
Gilead Sciences, Inc.'s strong sales growth in Veklury, Livdelzi, and Trodelvy shows promise for long-term financial success.
Mycotopia Therapies, Inc. Announces Name Change to AIBiotics, Inc. and Symbol Change to AIBT
Mycotopia Therapies Inc. dba AIBotics ("AIBotics" or the "Company") (OTC: TPIA) and a wholly owned subsidiary of Ehave (OTC: EHVVF), a developer and manager of ...